The Equine Eye Clinic Limited 10634980 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 10634980 2023-04-01 2024-03-31 10634980 2024-03-31 10634980 bus:Director4 1 2024-03-31 10634980 bus:OrdinaryShareClass1 2024-03-31 10634980 bus:OrdinaryShareClass2 2024-03-31 10634980 bus:OrdinaryShareClass3 2024-03-31 10634980 bus:OrdinaryShareClass4 2024-03-31 10634980 core:RetainedEarningsAccumulatedLosses 2024-03-31 10634980 core:ShareCapital 2024-03-31 10634980 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10634980 core:FurnitureFittingsToolsEquipment 2024-03-31 10634980 bus:SmallEntities 2023-04-01 2024-03-31 10634980 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 10634980 bus:FullAccounts 2023-04-01 2024-03-31 10634980 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 10634980 bus:RegisteredOffice 2023-04-01 2024-03-31 10634980 bus:CompanySecretaryDirector1 2023-04-01 2024-03-31 10634980 bus:Director2 2023-04-01 2024-03-31 10634980 bus:Director4 1 2023-04-01 2024-03-31 10634980 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 10634980 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 10634980 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 10634980 bus:OrdinaryShareClass4 2023-04-01 2024-03-31 10634980 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 10634980 core:ComputerEquipment 2023-04-01 2024-03-31 10634980 core:FurnitureFittings 2023-04-01 2024-03-31 10634980 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 10634980 core:PlantMachinery 2023-04-01 2024-03-31 10634980 core:KeyManagementPersonnel 2023-04-01 2024-03-31 10634980 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-04-01 2024-03-31 10634980 countries:EnglandWales 2023-04-01 2024-03-31 10634980 2023-03-31 10634980 bus:Director4 1 2023-03-31 10634980 core:FurnitureFittingsToolsEquipment 2023-03-31 10634980 2022-04-01 2023-03-31 10634980 2023-03-31 10634980 bus:CompanySecretaryDirector1 1 2023-03-31 10634980 bus:Director2 1 2023-03-31 10634980 bus:OrdinaryShareClass1 2023-03-31 10634980 bus:OrdinaryShareClass2 2023-03-31 10634980 bus:OrdinaryShareClass3 2023-03-31 10634980 bus:OrdinaryShareClass4 2023-03-31 10634980 core:AcceleratedTaxDepreciationDeferredTax 2023-03-31 10634980 core:RetainedEarningsAccumulatedLosses 2023-03-31 10634980 core:ShareCapital 2023-03-31 10634980 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 10634980 core:FurnitureFittingsToolsEquipment 2023-03-31 10634980 bus:CompanySecretaryDirector1 1 2022-04-01 2023-03-31 10634980 bus:Director2 1 2022-04-01 2023-03-31 10634980 bus:CompanySecretaryDirector1 1 2022-03-31 10634980 bus:Director2 1 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10634980

Prepared for the registrar

The Equine Eye Clinic Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2024

 

The Equine Eye Clinic Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

The Equine Eye Clinic Limited

Company Information

Directors

Mr T N L Knott

Mrs M Knott

Company secretary

Mrs M Knott

Registered office

Old Bournstream House
Bournstream
Wotton-Under-Edge
Gloucestershire
GL12 7PA

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

The Equine Eye Clinic Limited

(Registration number: 10634980)
Balance Sheet as at 31 March 2024

Note

2024
 £

2023
 £

Fixed assets

 

Tangible assets

4

463

4,622

Current assets

 

Debtors

5

48,857

64,217

Cash at bank and in hand

 

21,345

8,329

 

70,202

72,546

Creditors: Amounts falling due within one year

6

(15,928)

(8,237)

Net current assets

 

54,274

64,309

Total assets less current liabilities

 

54,737

68,931

Deferred tax liabilities

7

-

(636)

Net assets

 

54,737

68,295

Capital and reserves

 

Called up share capital

200

200

Profit and loss account

54,537

68,095

Total equity

 

54,737

68,295

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 6 October 2024 and signed on its behalf by:
 


Mr T N L Knott
Director


Mrs M Knott
Company secretary and director

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Old Bournstream House
Bournstream
Wotton-Under-Edge
Gloucestershire
GL12 7PA

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing on the initial transaction dates.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

15% straight line

Plant and machinery

33.33% straight line

Computer equipment

50% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 1).

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost

At 1 April 2023

29,993

29,993

Additions

653

653

At 31 March 2024

30,646

30,646

Depreciation

At 1 April 2023

25,371

25,371

Charge for the year

4,812

4,812

At 31 March 2024

30,183

30,183

Carrying amount

At 31 March 2024

463

463

At 31 March 2023

4,622

4,622

 

5

Debtors

2024
 £

2023
 £

Trade debtors

3,828

1,572

Other debtors

45,029

62,645

 

48,857

64,217

 

6

Creditors

2024
 £

2023
 £

Due within one year

Social security and other taxes

12,278

5,707

Accrued expenses

3,650

2,530

15,928

8,237

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2024

 

7

Deferred tax

Deferred tax assets and liabilities

2023

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

636

636

 

8

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary A of £1 each

99

99

99

99

Ordinary B of £1 each

99

99

99

99

Ordinary C of £1 each

1

1

1

1

Ordinary D of £1 each

1

1

1

1

 

200

200

200

200

The difference classes of share referred to above carry separate rights to dividends but, in all other significant respects, rank pari passu.

 

9

Related party transactions

Key management personnel

Key management personnel are considered to be the directors of the company.

Summary of transactions with key management

As at the balance sheet date the company was owed by the directors' of the company £19,434 (2023: £34,335). These amounts are included within other debtors (2023: other debtors). There are no fixed repayment terms and interest is charged on the amount owed to the company.

An analysis of the movement in the amount owed to the company from the directors is as follows:

 

Transactions with directors

2024

At 1 April 2023
£

Advances to director
£

Repayments by director
£

At 31 March 2024
£

Mr T and Mrs M Knott

34,335

15,793

(30,694)

19,434

         
       

 

2023

At 1 April 2022
£

Advances to director
£

Repayments by director
£

At 31 March 2023
£

Mr T N L Knott

61,878

4,688

(34,212)

32,354

         
       

Mrs M Knott

-

22,137

(20,156)

1,981